Karriereverlauf von Sandeep C. Kulkarni
Ehemalige bekannte Positionen von Sandeep C. Kulkarni
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| IMMUNOVANT, INC. | Geschäftsführer | 01.10.2018 | 01.12.2019 |
Immunovant, Inc. /Old/
 Immunovant, Inc. /Old/ BiotechnologyHealth Technology Immunovant, Inc. is a biopharmaceutical company, which engages in the development of therapies for autoimmune diseases. It focuses on its product pipeline, IMVT-1401, which is a human recombinant anti-neonatal Fc receptor monoclonal antibody for the treatment of IgG mediated diseases. The company is headquartered in New York, NY. | Geschäftsführer | - | - |
Statistik
International
| Vereinigte Staaten | 3 |
Operativ
| Chief Operating Officer | 2 |
Sektoral
| Health Technology | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| IMMUNOVANT, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Immunovant, Inc. /Old/
Immunovant, Inc. /Old/ BiotechnologyHealth Technology Immunovant, Inc. is a biopharmaceutical company, which engages in the development of therapies for autoimmune diseases. It focuses on its product pipeline, IMVT-1401, which is a human recombinant anti-neonatal Fc receptor monoclonal antibody for the treatment of IgG mediated diseases. The company is headquartered in New York, NY. | Health Technology |
- Börse
- Insiders
- Sandeep C. Kulkarni
- Erfahrung
